Johnson & Johnson Withdraws Simponi in Germany Amid Mounting Product Recalls

February 22, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Bloomberg -- Johnson & Johnson recalled batches of its Simponi arthritis treatment in Germany and withheld shipments that will cause shortages in Europe, adding to glitches that cost the company more than $900 million last year.

Twitter
LinkedIn
Facebook
Email
Print

Europe

Johnson & Johnson Family of Companies